Seventh Sense Biosystems is developing novel products to optimize the interface of diagnostic medicine and the healthcare consumer by dramatically simplifying blood sampling and testing.  The Seventh Sense On Vivo™ platform will enable diagnostic testing to be performed safely and painlessly by virtually anyone, anywhere. The Company's proprietary, single-step Touch Activated Phlebotomy™ (TAP™) technology can be combined with a variety of diagnostic assays for rapid results. TAP’s revolutionary sampling capabilities may also integrate with analytical systems to vastly improve the patient and clinician experience.  Seventh Sense is a Flagship VentureLabs company.  

Doug Cole is on the Board of Directors.